prscreening_telefoninterview_frste_kontakt

prscreening_telefoninterview_frste_kontakt

prscreening_telefoninterview_frste_kontakt
Fields in the prscreening_telefoninterview_frste_kontakt resource.
Name Title Type Description
event The unique name of the event string The unique name identifying the event when the form was filled in.
center Research center string The research center where the data item was recorded.
date_v0 date_v0 date Date of visit. Visit 0.
staff_initials_v0 staff_initials_v0 string Initials of the study staff member responsible for conducting the visit. Visit 0.
aim_phoneinterview_v0 aim_phoneinterview_v0 string Aim of telephone interview explained to the participant. Completed by study staff. Visit 0.
oral_constent_v0 oral_constent_v0 string Whether the participant provided verbal consent for registration of information from this telephone interview in REDCap. Completed by study staff. Visit 0.
short_intro_onlimit_v0 short_intro_onlimit_v0 string Study purpose explained to the participant during the telephone interview. Completed by study staff. Visit 0.
info_read_v0 info_read_v0 string Whether the participant has read the written study information. Recorded by study staff. Visit 0.
info_questions_v0 info_questions_v0 string Whether the participant has any questions at this time regarding the written information. Recorded by study staff. Visit 0.
age_v0 age_v0 number Participant’s age in years. Self-reported by the participant. Visit 0.
t2d_diagnose_v0 t2d_diagnose_v0 string Diagnosis status of type 2 diabetes. Self-reported by participant. Visit 0.
t2d_duration_v0 t2d_duration_v0 number Number of years since participant was diagnosed with type 2 diabetes. Self-reported by participant. Visit 0. Not filled out from i1050.
sp_consent_v0 sp_consent_v0 string Participant consent for lookup in SP. Visit 0. Filled out from i1050.
t2d_duration_v01 t2d_duration_v01 string Number of years since participant was diagnosed with type 2 diabetes. Self-reported by participant. Visit 0. Filled out from i1050. Derived using the formula: [stamdata_arm_1][t2d_duration_stamdata]
hba1c_v0 hba1c_v0 string Recent HbA1c value in mmol/mol. Visit 0.
height_v0 height_v0 number Participant’s estimated height in meter. Self-reported by participant. Visit 0.
weight_v0 weight_v0 number Participant’s estimated weight in kilograms. Self-reported by participant. Visit 0.
bmi_v0 bmi_v0 string Body Mass Index (BMI) in kg/m², calculated from estimated participant’s self-reported weight and height. Visit 0. Derived using the formula: round(([weight_v0])/(([height_v0])^(2)), 1)
weight_change_v0 weight_change_v0 string Participant’s self-reported weight stability over the past 3 months (±3 kg). Visit 0.
weight_difference_v0 weight_difference_v0 number Participant’s self-reported weight change over the past 3 months, stated in kilograms (gain or loss). Visit 0.
insulin_use_v0 insulin_use_v0 string Insulin treatment status within the past 6 months (any type). Self-reported by participant. Visit 0.
heart_failure_v0 heart_failure_v0 string Presence of heart failure with reduced ejection fraction (EF < 40%) and current or planned treatment with SGLT-2 inhibitors. Self-repported by participant. Visit 0.
cvd_v0 cvd_v0 string Established CVD with prescribed GLP-1 RA and/or SGLT-2 inhibitor. Visit 0. Added from i1022.
kidney_function_v0 kidney_function_v0 string Presence of kidney disease (eGFR < 60 ml/min) and current or planned treatment with SGLT-2 inhibitors. Self-reported by participant. Visit 0.
physical_health_v0 physical_health_v0 string Presence of physical health problems that prevent participation in planned physical activity during the intervention. Self-reported by participant. Visit 0.
physical_health_example_v0 physical_health_example_v0 string Description of physical health problems preventing participation in planned physical activity during the intervention. Self-reported by participant. Visit 0.
food_allergies_v0 food_allergies_v0 string Presence of dietary restrictions or allergies that prevent adherence to the planned dietary intervention. Self-reported by participant. Visit 0.
food_allergies_example_v0 food_allergies_example_v0 string Description of dietary restrictions or food allergies preventing adherence to the planned diet. Self-reported by participant. Visit 0.
pregnant_v0 pregnant_v0 string Participant’s pregnancy status or plans to become pregnant within the next year. Self-reported by participant. Visit 0.
antabus_v0 antabus_v0 string Participant’s history of alcohol or substance abuse, or current treatment for alcohol dependence (including pharmacological treatment). Self-reported by participant. Visit 0.
psychiatric_disease_v0 psychiatric_disease_v0 string Presence of psychiatric disease. Self-reported by participant. Visit 0.
psychiatric_disease_specific_v0 psychiatric_disease_specific_v0 string Specification of psychiatric disease. Visit 0. Added from ID i1022.
psychiatric_disease_medication_change_v0 psychiatric_disease_medication_change_v0 string Any changes in psychiatric medication within the last 3 months. Visit 0. Added from ID i1022.
psychiatric_disease_medication_change_specific_v0 psychiatric_disease_medication_change_specific_v0 string Specification of changes in psychiatric medication within the last 3 months. Visit 1. Visit 0. Added from ID i1022.
psychiatric_hospitalization_v0 psychiatric_hospitalization_v0 string Whether the participant has had any acute psychiatric visits or hospital admissions within the last 6 months. Visit 0. Added from ID i1022.
psychiatric_disease_barrier_v0 psychiatric_disease_barrier_v0 string Whether the participant’s mental condition (other than those previously mentioned) is considered to prevent study participation. Assesed by study staff. Visit 0. Added from ID i1022.
psychiatric_disease_barrier_reason_v0 psychiatric_disease_barrier_reason_v0 string Specify the reason why the mental condition is considered to prevent study participation. Recorded by study staff. Visit 0. Added from ID i1022.
binge_eating_v0 binge_eating_v0 string Diagnosis status of binge eating disorder. Self-reported by participant. Visit 0.
other_intervention_v0 other_intervention_v0 string Participation status or plans to participate in another intervention study (medical or lifestyle) involving alternative treatment. Self-reported by participant. Visit 0.
language_barrier_v0 language_barrier_v0 string Participant’s difficulties in understanding Danish, both written and spoken. Self-reported by participant. Visit 0.
compliance_risk_v0 compliance_risk_v0 string Assessment of whether the participant is likely to comply with study procedures and/or interventions (e.g., attendance, measurements, counselling). Assessed by study staff. Visit 0.
compliance_risk_expl_v0 compliance_risk_expl_v0 string Notes explaining the assessment of the participant’s likelihood to comply with study procedures and/or interventions. Reported by study staff. Visit 0.
eligible_v0 eligible_v0 string Assessment of whether the participant remains eligible to participate in the study after prescreening. Recorded by study staff. Visit 0.
continue_v0 continue_v0 string Whether the participant wishes to continue in the study after the telephone interview - prescreening. Recorded by study staff. Visit 0.
visit1_booking_type_v0 visit1_booking_type_v0 string Participant’s preference regarding the booking of the information and screening visit. Recorded by study staff. Visit 0. Field introduced from i1021.
book_sp_v0 book_sp_v0 string Booking of V1 in SP. Visit 0. Field introduced from i1021.
book_outlook_v0 book_outlook_v0 string Booking of V1 in outlook. Visit 0. Field introduced from i1021.
mail_v0 mail_v0 string Secure email with information about the screening visit has been sent to the participant. Visit 0. Field introduced from i1021.
relative_v1_v0 relative_v1_v0 string Participant’s preference to have a relative accompany them to Visit 1. Recorded by study staff. Visit 0.
book_online_meeting_v0 book_online_meeting_v0 string Booking of online information meeting. Visit 0. Field introduced from i1021.
comments_end_v0 comments_end_v0 string General comments and observations recorded. Free-text notes by study staff. Visit 0.
treatment_v0___1 Livstilbehandling (f.eks. forløb hos diætist, træningsforløb eller andet) boolean Current treatment approach for type 2 diabetes - lifestyle changes and/or oral antidiabetic medication and/or GLP-1 receptor agonist. Self-reported by participant. Visit 0.
treatment_v0___2 Oral antidiabetisk medicin boolean Current treatment approach for type 2 diabetes - lifestyle changes and/or oral antidiabetic medication and/or GLP-1 receptor agonist. Self-reported by participant. Visit 0.
treatment_v0___3 GLP-1 RA boolean Current treatment approach for type 2 diabetes - lifestyle changes and/or oral antidiabetic medication and/or GLP-1 receptor agonist. Self-reported by participant. Visit 0.